Assessment of idiopathic rapid-eye-movement sleep behavior disorder by transcranial sonography, olfactory function test, and FP-CIT-SPECT

Mov Disord. 2008 Mar 15;23(4):596-9. doi: 10.1002/mds.21908.

Abstract

Idiopathic rapid-eye-movement (REM) sleep behavior disorder (iRBD) has been suggested to be a risk factor for subsequent development of neurodegenerative disorders, especially Parkinson's disease (PD) and other alpha-synucleinopathies. At present, it is not possible to predict whether or not an iRBD patient will eventually develop PD. Here, we report 5 iRBD patients who underwent a test battery comprising a neurological examination (including UPDRS rating), mini mental state examination testing, transcranial sonography, olfactory function testing, and presynaptic dopamine transporter imaging with FP-CIT-SPECT. Our preliminary data show the diverse pattern of individual combinations of pathological findings when a multimodal assessment approach is applied in this patient group. Large-size longitudinal studies in iRBD patients are required to evaluate the usefulness of diagnostic tests to identify the subgroup of iRBD patients that is prone to develop PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cognition Disorders / diagnosis
  • Cognition Disorders / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Olfaction Disorders / diagnosis
  • Olfaction Disorders / epidemiology*
  • Olfaction Disorders / physiopathology*
  • REM Sleep Behavior Disorder / diagnosis*
  • REM Sleep Behavior Disorder / epidemiology*
  • Radiopharmaceuticals*
  • Severity of Illness Index
  • Substantia Nigra / diagnostic imaging
  • Substantia Nigra / metabolism
  • Substantia Nigra / physiopathology
  • Tomography, Emission-Computed, Single-Photon*
  • Tropanes*
  • Ultrasonography, Doppler, Transcranial / methods*

Substances

  • Radiopharmaceuticals
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane